Anavar (Oxandrolone) by Meditech is a pharmaceutical-grade oral anabolic-androgenic steroid formulated at 10 mg per tablet, supplied in boxes of 100 tablets or 2 × 50 tablet blister packs. Oxandrolone is a DHT-derived 17α-alkylated anabolic-androgenic compound with an extensive clinical and pharmacological research history spanning decades, distinguished within the oral anabolic steroid class by its notably mild androgenic profile, absence of aromatization, and documented tolerability in both male and female research subject populations — characteristics that have made it one of the most extensively studied oral anabolic compounds across diverse clinical research applications.
 
✔ Key Research Insights
Studied for its DHT-derived pharmacological profile, including its documented absence of aromatization to estrogen, low androgenic potency relative to anabolic activity, and minimal suppressive effects on endogenous testosterone production at lower dose ranges in comparative anabolic-androgenic steroid research
Investigated for its effects on lean mass preservation and protein synthesis parameters in research subjects across caloric deficit and recomposition protocols, with documented lean mass retention properties referenced consistently in comparative oral anabolic steroid literature
Researched for its influence on strength indices and muscular endurance parameters in documented subject populations, with strength gains documented as disproportionately pronounced relative to mass accrual in comparative anabolic research observations
Examined for its effects on fat metabolism parameters, with documented influences on visceral and subcutaneous fat reduction referenced in comparative anabolic-androgenic steroid research and clinical endocrinology literature
Documented for its comparatively favorable tolerability profile in female research subjects relative to other anabolic-androgenic compounds, with a lower incidence of virilization effects at lower dose ranges noted consistently in comparative steroid research — a characteristic of significant clinical research interest distinguishing oxandrolone from most other anabolic-androgenic compounds
Researched for its established clinical indications including muscle wasting associated with HIV/AIDS, severe burn injury recovery, Turner syndrome, and involuntary weight loss conditions, representing an unusually broad spectrum of documented therapeutic applications for an anabolic-androgenic compound in clinical medicine literature
Manufactured by Meditech to pharmaceutical-grade purity and consistent potency standards
 
📦 Product Specifications
Manufacturer: Meditech
Product: Anavar
Molecule: Oxandrolone
Concentration: 10 mg per tablet
Form: Oral tablet
Volume: 100 tablets per box or 2 × 50 tablet blister packs
Dosage considerations may vary. Consulting a qualified professional is recommended.
 
⚙ How It Works
Oxandrolone is a 17α-alkylated DHT-derived anabolic-androgenic steroid administered orally. The 17α-alkylation modification confers resistance to hepatic first-pass metabolism, enabling consistent oral bioavailability in research subjects — a pharmacokinetic advantage accompanied by the hepatotoxic considerations documented in clinical literature as relevant to extended oral anabolic steroid administration, though oxandrolone's hepatotoxic profile is documented in comparative research as among the milder of the 17α-alkylated oral anabolic compounds. Oxandrolone exerts its primary anabolic effects through androgen receptor binding in muscle tissue, with downstream influences on protein synthesis and nitrogen retention documented in research literature. Its DHT-derived structure confers complete resistance to aromatization via the aromatase enzyme, resulting in the documented absence of estrogenic effects including fluid retention across research subject populations. Unlike testosterone and nandrolone-based compounds, oxandrolone does not undergo conversion to more potent androgens in target tissues, contributing to its documented mild androgenic profile and comparatively reduced suppression of the hypothalamic-pituitary-testicular axis at lower dose ranges in male research subjects. In female research subjects, oxandrolone's mild androgenic index has been documented in comparative anabolic steroid research to produce a lower incidence of virilization effects relative to other anabolic-androgenic compounds at equivalent anabolic doses — a pharmacological characteristic of particular clinical research relevance supporting its documented use in female populations across both therapeutic and research contexts. Established clinical research applications documented in medical literature include lean mass restoration in HIV/AIDS-associated wasting, accelerated recovery in severe burn injury, growth promotion in Turner syndrome, and management of involuntary weight loss conditions — representing a breadth of therapeutic documentation uncommon among oral anabolic-androgenic compounds.
 
⭐ Product Overview
Manufactured by Meditech to pharmaceutical-grade purity and consistent potency standards
DHT-derived oral anabolic compound with a well-documented mild androgenic profile, absence of aromatization, and comparatively favorable tolerability characteristics in both male and female research subject populations
One of the most clinically documented oral anabolic-androgenic compounds with established therapeutic applications across multiple medical specialties referenced in international clinical literature
Available in both box and blister pack formats providing 100 tablets per unit with consistent 10 mg per tablet concentration for accurate and flexible dose titration
Widely referenced in anabolic pharmacology, endocrinological, and clinical medicine research literature under the oxandrolone and Anavar designations